23 results

• Side Effects of Neurontin, Similar Drugs May Worsen COPD Symptoms, Researchers Warn

  January 17, 2024

  Martha Garcia

  A new study links anticonvulsants like Neurontin and Lyrica to an increased risk of respiratory problems in COPD patients.

• Study Finds Questionable Prescribing of Antiepileptic Drugs to Nursing Home Patients with Dementia

  November 14, 2022

  Russell Maas

  A new study suggests anti-seizure medications like Depakote and Neurontin are being used to replace antipsychotics as "chemical restraints" on nursing home dementia patients.

• Problems with Gabapentin Misuse are a Sign of Improper Prescribing: Report

  September 13, 2022

  Martha Garcia

  A new report warns that off-label prescribing is a driving factor behind increasing gabapentin misuse and overdoses.

• CDC Warns About Overdose Deaths Linked to Gabapentin Abuse

  July 1, 2022

  Irvin Jackson

  The CDC warns that Gabapentin, an epilepsy drug, is being linked to an increasing number of overdose deaths nationwide.

• Public Citizen Calls For Gabapentin To Be Classified As a Controlled Substance

  February 10, 2022

  Martha Garcia

  Public Citizen has petitioned the FDA to classified gabapentin, the active ingredient in Neurontin and other, similar epilepsy drugs, as a controlled substance due to increasing drug abuse problems.

• Neurontin, Lyrica, Similar Drugs May Cause Respiratory Problems When Used With Opioids: FDA

  December 23, 2019

  Irvin Jackson

  A new FDA warning links nerve pain drugs like Neurontin and Lyrica to an increased risk of breathing problems when used with opioids or given to patients with pre-existing respiratory problems.

• Neurontin, Gablofen Increasingly Used In Suicide Attempts: Study

  December 5, 2019

  Martha Garcia

  A new study finds increasing reports of suicide attempts involving Neurontin and Gablofen.

• Neurontin Linked To Increased Risk of Suicide, Overdoses and Accidents: Study

  June 19, 2019

  Russell Maas

  Neurontin and similar drugs are linked to an increased risk of suicide, overdose and violent behavior, according to the findings of a new study.

• Neurontin Settlement Proposed for $325M to Resolve Marketing Lawsuits

  June 3, 2014

  Irvin Jackson

  Pfizer will pay $345 million to settle Neurontin off-label marketing charges brought by insurance companies and health care benefits providers.

• Neurontin Class Action Over Marketing Claims Settled by Pfizer for $190M

  April 22, 2014

  Irvin Jackson

  Pfizer has agreed to a $190 million Neurontin settlement agreement to address charges that the company used illegal tactics to keep the cost of the drug artificially high.